Resultado da Busca
Agents Chemother. Antimicrobial Agents and Chemotherapy è una revisione paritaria di comunicazioni scientifiche pubblicate dalla American Society for Microbiology. La rassegna tratta di agenti antimicrobici, antivirali, antimicotici e antiparassitari e chemioterapia . Il caporedattore è Louis B. Rice ( Brown University ).
Neurology. Chemotherapy-induced peripheral neuropathy (CIPN) is a nerve -damaging side effect of antineoplastic agents in the common cancer treatment, chemotherapy. [1] CIPN afflicts between 30% and 40% of patients undergoing chemotherapy. Antineoplastic agents in chemotherapy are designed to eliminate rapidly dividing cancer cells, but they ...
Specialty. oncology. [ edit on Wikidata] Cyclophosphamide Methotrexate Fluorouracil (CMF) is a commonly used regimen of breast cancer chemotherapy that combines three anti-cancer agents: cyclophosphamide, methotrexate, and 5-fluorouracil (5-FU). [1]
It is a coordination complex of platinum that is used as a chemotherapy medication used to treat a number of cancers. [3] These include testicular cancer, ovarian cancer, cervical cancer, bladder cancer, head and neck cancer, esophageal cancer, lung cancer, mesothelioma, brain tumors and neuroblastoma. [3] It is given by injection into a vein.
La chemioterapia (dall'inglese chemo-, tratto da chemical, "chimico" e dal greco θεραπεία, therapèia, " terapia ") è la branca della farmacologia che sviluppa a fini terapeutici dei farmaci con capacità di distruzione quanto più mirata e selettiva possibile di manifestazioni biologiche patologiche. In base alla loro natura, si ...
Bortezomib, sold under the brand name Velcade among others, is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma. [2] This includes multiple myeloma in those who have and have not previously received treatment. [3] It is generally used together with other medications. [3]
Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. In 1983, Coates et al. found that patients receiving chemotherapy ranked nausea and vomiting as the first and second most severe side effects, respectively. Up to 20% of patients receiving highly emetogenic agents in this ...
